ROCHESTER, N.Y. -- Bausch & Lomb, the global eye health company, today announced R. Kerry Clark and Robert J. Palmisano have joined its board of directors.
“We are adding two outstanding business leaders with broad and relevant experience,” said Gerald M. Ostrov, chairman and chief executive officer, Bausch & Lomb. “Choices like these help us become better positioned for long-term growth. We welcome Kerry and Bob and look forward to benefiting from their unique backgrounds and expertise.”
Mr. Clark retired in September 2009 as chairman and chief executive officer of Cardinal Health, Inc. (NYSE: CAH), a Fortune 20 company. Under his leadership, Cardinal Health acquired numerous medical technologies that helped the company expand its service to hospitals, pharmacies and clinicians across the United States. Before his leadership at Cardinal Health, Mr. Clark spent more than 30 years at Procter & Gamble Co., where he last served as vice chairman of the board. Mr. Clark is currently a director of Textron, General Mills and Hauser Capital Partners. He holds a bachelor’s degree from Queens University.
Mr. Palmisano is the president, chief executive officer and director of ev3 Inc. (Nasdaq: EVVV), a leading global provider of technology for treating peripheral vascular disease and neurovascular diseases. Prior to ev3, Mr. Palmisano was president and chief executive officer for IntraLase Corp., which designed and developed laser products for vision correction, until IntraLase was acquired by Advanced Medical Optics, Inc. He also served as president and chief executive officer for pharmaceuticals firm MacroChem Corporation and Summit Autonomous, Inc., a global medical products company later acquired by Alcon, Inc. Mr. Palmisano has a long history with Bausch & Lomb, holding various executive positions within the company from 1985 to 1996. His last role with Bausch & Lomb was as senior vice president and president of its eyewear division. He holds a bachelor’s degree from Providence College.
Mr. Clark and Mr. Palmisano join board members Joseph P. Landy, Elizabeth H. Weatherman and Sean D. Carney, all managing directors of Warburg Pincus LLC; D. Scott Mackesy, general partner, Welsh Carson Anderson & Stowe; Richard Wallman, retired chief financial officer, Honeywell International, Inc.; and Gerald M. Ostrov.
About Bausch & Lomb
Bausch & Lomb is dedicated to bringing visionary ideas to eye health. Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pharmaceuticals. The Bausch & Lomb name is one of the best-known and most respected healthcare brands in the world. Founded in 1853, the company is headquartered in Rochester, N.Y., and employs more than 10,000 people worldwide. Its products are available in more than 100 countries. More information is available at www.bausch.com.